Mary K. Joseph

4.5k total citations
10 papers, 450 citations indexed

About

Mary K. Joseph is a scholar working on Molecular Biology, Oncology and Computational Theory and Mathematics. According to data from OpenAlex, Mary K. Joseph has authored 10 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Computational Theory and Mathematics. Recurrent topics in Mary K. Joseph's work include Cell death mechanisms and regulation (5 papers), Computational Drug Discovery Methods (2 papers) and RNA Interference and Gene Delivery (2 papers). Mary K. Joseph is often cited by papers focused on Cell death mechanisms and regulation (5 papers), Computational Drug Discovery Methods (2 papers) and RNA Interference and Gene Delivery (2 papers). Mary K. Joseph collaborates with scholars based in United States and United Kingdom. Mary K. Joseph's co-authors include Haichao Zhang, Saul H. Rosenberg, Shi‐Chung Ng, Paul Nimmer, Andrew M. Petros, David A. Betebenner, Steven W. Elmore, Jürgen Dinges, Mark G. Bures and David G. Nettesheim and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Oncogene.

In The Last Decade

Mary K. Joseph

10 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary K. Joseph United States 8 367 102 95 79 35 10 450
Marc R. Arnone United States 7 474 1.3× 122 1.2× 201 2.1× 113 1.4× 22 0.6× 7 620
Michael R. Gehring United States 10 317 0.9× 69 0.7× 125 1.3× 79 1.0× 13 0.4× 13 446
James R. Porter United States 8 350 1.0× 59 0.6× 59 0.6× 60 0.8× 25 0.7× 12 483
Mauro Angiolini Italy 10 387 1.1× 94 0.9× 139 1.5× 247 3.1× 50 1.4× 14 587
Henrik Moebitz Switzerland 5 325 0.9× 58 0.6× 119 1.3× 105 1.3× 25 0.7× 8 441
Jason Boggs United States 10 441 1.2× 59 0.6× 145 1.5× 74 0.9× 31 0.9× 15 572
Deborah Moshinsky United States 11 270 0.7× 59 0.6× 166 1.7× 31 0.4× 32 0.9× 14 431
Masaki Gouda Japan 9 235 0.6× 34 0.3× 85 0.9× 49 0.6× 32 0.9× 11 385
Aras Emdadi United States 10 359 1.0× 103 1.0× 71 0.7× 139 1.8× 11 0.3× 10 479
Pascal Furet Switzerland 7 397 1.1× 60 0.6× 247 2.6× 189 2.4× 17 0.5× 7 565

Countries citing papers authored by Mary K. Joseph

Since Specialization
Citations

This map shows the geographic impact of Mary K. Joseph's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary K. Joseph with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary K. Joseph more than expected).

Fields of papers citing papers by Mary K. Joseph

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary K. Joseph. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary K. Joseph. The network helps show where Mary K. Joseph may publish in the future.

Co-authorship network of co-authors of Mary K. Joseph

This figure shows the co-authorship network connecting the top 25 collaborators of Mary K. Joseph. A scholar is included among the top collaborators of Mary K. Joseph based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary K. Joseph. Mary K. Joseph is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Tahir, Stephen K., John Wass, Mary K. Joseph, et al.. (2010). Identification of Expression Signatures Predictive of Sensitivity to the Bcl-2 Family Member Inhibitor ABT-263 in Small Cell Lung Carcinoma and Leukemia/Lymphoma Cell Lines. Molecular Cancer Therapeutics. 9(3). 545–557. 59 indexed citations
2.
Shoemaker, Alex R., Michael J. Mitten, Anatol Oleksijew, et al.. (2006). The Bcl-2 Family Inhibitor ABT-263 Shows Significant Anti-Tumor Efficacy in Models of B Cell Non-Hodgkin’s Lymphoma.. Blood. 108(11). 825–825. 2 indexed citations
3.
Petros, Andrew M., Jürgen Dinges, David J. Augeri, et al.. (2005). Discovery of a Potent Inhibitor of the Antiapoptotic Protein Bcl-x L from NMR and Parallel Synthesis. Journal of Medicinal Chemistry. 49(2). 656–663. 229 indexed citations
4.
Joseph, Mary K., Larry R. Solomon, Andrew M. Petros, et al.. (2004). Divergence of Genbank and human tumor Bcl-2 sequences and implications for binding affinity to key apoptotic proteins. Oncogene. 23(3). 835–838. 4 indexed citations
5.
Zhai, Dayong, Ke Ning, Haichao Zhang, et al.. (2003). Characterization of the anti-apoptotic mechanism of Bcl-B. Biochemical Journal. 376(1). 229–236. 29 indexed citations
6.
Zhang, Haichao, Paul Nimmer, Saul H. Rosenberg, Shi‐Chung Ng, & Mary K. Joseph. (2002). Development of a high-throughput fluorescence polarization assay for Bcl-xL. Analytical Biochemistry. 307(1). 70–75. 68 indexed citations
7.
Luo, Yan, Mary K. Joseph, Christopher Butler, et al.. (2001). Abrogation of G2 checkpoint specifically sensitize p53 defective cells to cancer chemotherapeutic agents.. PubMed. 21(1A). 23–8. 28 indexed citations
8.
McPartland, Richard P., et al.. (1983). Isolation and partial characterization of rat urinary esterase A2. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 742(1). 100–108. 11 indexed citations
9.
Joseph, Mary K., Mats A. Fernström, & Melvyn S. Soloff. (1982). Switching of beta- to alpha-tubulin phosphorylation in uterine smooth muscle of parturient rats.. Journal of Biological Chemistry. 257(19). 11728–11733. 8 indexed citations
10.
Rapp, John P., Mary K. Joseph, & Richard P. McPartland. (1982). Proteins binding to kallikrein and esterase A2 in the urine of salt-sensitive and salt-resistant rats.. Hypertension. 4(4). 545–555. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026